American California Pharmaceutical Group

American California Pharmaceutical Group, Inc. (ACPG) is a California-based subsidiary of China Sky One Medical, Inc. (CSKI), serving as a holding company for the group's pharmaceutical operations in China. The company specializes in the development, manufacture, and distribution of external-use Traditional Chinese Medicine (TCM) and over-the-counter (OTC) products, including medicated patches, ointments, and sprays. Its lead commercial products historically included the "Slim Patch" for weight loss and various diagnostic kits for infectious diseases. In 2012, the U.S. Securities and Exchange Commission (SEC) charged the company and its parent with fraud for fabricating nearly $20 million in export sales, leading to its delisting from NASDAQ. The company is currently considered inactive, with its corporate status in California reported as suspended.